BACKGROUND: Canine factor VII (cFVII) deficiency, an autosomal recessive trait originally identified in research Beagles, is associated with a mild to moderate bleeding tendency. OBJECTIVE: Our aim was to identify and characterize the mutation causing cFVII deficiency. METHODS: In order to sequence the coding regions of the cFVII gene, we cloned the cFVII cDNA. Genomic DNA and plasma from FVII-deficient Beagles and obligate carriers were utilized. RESULTS: In all FVII-deficient dogs, we identified a single causative G to A missense mutation in exon 5, encoding the second epidermal growth factor-like domain, resulting in substitution of glycine 96 by glutamic acid, with plasma FVII coagulant activity of <or = 4% in affected Beagles. In vitro expression indicated that the majority (96%) of cFVII-G96E protein was retained intracellularly. In addition, analysis of purified recombinant wild-type and mutant cFVII proteins demonstrated reduced activity of the mutant (< 2%) compared with wild-type. Rotational thromboelastometry revealed a severe impairment of clotting activity in affected Beagles, and heterozygotes also exhibited changes in coagulation-based assays. Using a mutation-specific polymerase chain reaction/restriction digest that allows rapid identification of the G96E mutation, we surveyed a US research Beagle colony and identified a mutant allelic frequency of 31%. CONCLUSIONS: We have identified a single causative mutation for cFVII deficiency that may have implications for pharmacotoxicologic research, because reduced FVII coagulant activity may alter hemostatic and/or cardiovascular endpoints in this commonly used animal species.
BACKGROUND:Caninefactor VII (cFVII) deficiency, an autosomal recessive trait originally identified in research Beagles, is associated with a mild to moderate bleeding tendency. OBJECTIVE: Our aim was to identify and characterize the mutation causing cFVII deficiency. METHODS: In order to sequence the coding regions of the cFVII gene, we cloned the cFVII cDNA. Genomic DNA and plasma from FVII-deficient Beagles and obligate carriers were utilized. RESULTS: In all FVII-deficientdogs, we identified a single causative G to A missense mutation in exon 5, encoding the second epidermal growth factor-like domain, resulting in substitution of glycine 96 by glutamic acid, with plasma FVII coagulant activity of <or = 4% in affected Beagles. In vitro expression indicated that the majority (96%) of cFVII-G96E protein was retained intracellularly. In addition, analysis of purified recombinant wild-type and mutant cFVII proteins demonstrated reduced activity of the mutant (< 2%) compared with wild-type. Rotational thromboelastometry revealed a severe impairment of clotting activity in affected Beagles, and heterozygotes also exhibited changes in coagulation-based assays. Using a mutation-specific polymerase chain reaction/restriction digest that allows rapid identification of the G96E mutation, we surveyed a US research Beagle colony and identified a mutant allelic frequency of 31%. CONCLUSIONS: We have identified a single causative mutation for cFVII deficiency that may have implications for pharmacotoxicologic research, because reduced FVII coagulant activity may alter hemostatic and/or cardiovascular endpoints in this commonly used animal species.
Authors: G Inal Gultekin; K Raj; P Foureman; S Lehman; K Manhart; O Abdulmalik; U Giger Journal: J Vet Intern Med Date: 2012 Jul-Aug Impact factor: 3.333
Authors: T Knudsen; A T Kristensen; T C Nichols; H Agersø; A L Jensen; M Kjalke; M Ezban; M Tranholm Journal: Haemophilia Date: 2011-06-06 Impact factor: 4.287
Authors: Tom Knudsen; Mads Kjelgaard-Hansen; Mikael Tranholm; Bo Wiinberg; Jes T Clausen; Jens Jacob Hansen; Timothy C Nichols; Marianne Kjalke; Asger L Jensen; Annemarie T Kristensen Journal: Vet J Date: 2011-01-08 Impact factor: 2.688
Authors: Timothy C Nichols; Aaron M Dillow; Helen W G Franck; Elizabeth P Merricks; Robin A Raymer; Dwight A Bellinger; Valder R Arruda; Katherine A High Journal: ILAR J Date: 2009
Authors: Lucas P Carlstrom; Jackie K Jens; Marley E Dobyns; Merry Passage; Patricia I Dickson; N Matthew Ellinwood Journal: Comp Med Date: 2009-08 Impact factor: 0.982
Authors: Paris Margaritis; Elise Roy; Majed N Aljamali; Harre D Downey; Urs Giger; Shangzhen Zhou; Elizabeth Merricks; Aaron Dillow; Mirella Ezban; Timothy C Nichols; Katherine A High Journal: Blood Date: 2008-12-23 Impact factor: 22.113
Authors: Marta G P Castelhano; Gregory M Acland; Penelope A Ciccone; Elizabeth E Corey; Jason G Mezey; John C Schimenti; Rory J Todhunter Journal: J Am Vet Med Assoc Date: 2009-01-01 Impact factor: 1.936